-
Int J Epidemiol: Obesity or a direct link to an increased risk of dementia in people.
Time of Update: 2020-07-28
In a study published in the international journal, scientists from institutions such as University College London have found that obesity or a direct link to an increased risk of dementia in individua
-
Ann Rheum Dis: Severe new crown pneumonia inflammatory storm sarilumab uses sarilumab to block the efficacy of interleukin-6.
Time of Update: 2020-07-28
The study was designed to assess the safety and efficacy of using blocking interleukin in patients with severe neo-coronary pneumonia associated with systemic inflammatory storms An open label study
-
Ann Rheum Dis: Tumor necrosis factor inhibitors can slow the imaging progress of aggressive spina bifida.
Time of Update: 2020-07-28
Tumor necrosis factor inhibitors () have been shown to slow the imaging progress of aggressive spina bifida However, the limitation factors such as changes in disease activity, complex drug management
-
How can I prevent coronaviruses from invading host cells?
Time of Update: 2020-07-28
New Year's Day - How to prevent new coronaviruses from entering host cells to prevent infection? A group of biomedical scientists has found a solution Scientists led by the University of California, R
-
Cell: Terrible! Virus infection causes human-viral hybrid genes to produce human-viral chimeric proteins!
Time of Update: 2020-07-28
Scientists from the Icahn School of Medicine at Mount Sinai, the University of Glasgow Virus Research Center, the National Institute of Allergy and Infectious Diseases, led by professors at the Univer
-
Redseywe's good news again! Phase III clinical lying is effective in patients with COVID-19!
Time of Update: 2020-07-28
MATH ( UPI) -- The latest clinical trial results from Gilead, the maker of the antiviral drug Redseve, show more good news for the drug's efficacy Gilead said recently that in a trial involving multip
-
Express . . . Treatment of lupus nephritis, potential "best-in-class" therapy qualified by the FDA for priority review.
Time of Update: 2020-07-28
▎ Aurinia announced today that the US Food and Drug Administration (FDA) has accepted a new drug application (NDA) for voclosporin developed by the company as a potential therapeutic drug for lupus nephritis (LN).
-
Nature's big break! Clinical trials of precision treatment of lung cancer have been successful.
Time of Update: 2020-07-28
New Year's Day - A pioneering lung cancer study led by the UK Clinical Trials Team at the University of Birmingham Cancer Research Centre has highlighted important factors to consider in the next wave
-
Nat Med: A comprehensive summary of the harmful effects of COVID-19 on organs other than the lungs.
Time of Update: 2020-07-27
23, 2020 /PRNewswire/ -- At the start of the new crown pneumonia outbreak in New York City, Dr Aakriti Gupta realized just days after caring for critically ill patients that it was much more than a re
-
NEJM: Newly discovered cell types help predict and treat rheumatoid arthritis.
Time of Update: 2020-07-27
!--:page title" -- When Dana Orange's patient suddenly developed rheumatoid arthritis (RA), the consequences were catastrophic a woman who was so sore that she couldn't even bend her elbow and brush
-
JAMA: In the first few months of the pandemic, 35% of the additional deaths were related to causes other than COVID-19!
Time of Update: 2020-07-27
(!--: "page title" -- July 23, 2020 /PRNewswire/ -- The death rate in the United States has increased significantly since the emergence of COVID-19 But a recent study published in the Journal of the
-
Why is fluid dynamics critical to COVID-19 research?
Time of Update: 2020-07-27
July 23, 2020 /PRNewswire/ -- The impact of respiratory infections on humans has become the focus of attention it also shows that the biggest defense against health crises is government policy, which
-
How does coronavirus affect the brain?
Time of Update: 2020-07-27
!--webeditor:page title" -- July 23, 2020 /PRNewswire/ -- The COVID-19 pandemic has been going on for six months, and we are still learning about the power of the disease now have detailed reports sh
-
PNAS interpretation! Scientists have designed a special red blood cell-driven immunotarget technology that could help develop better disease prevention vaccines!
Time of Update: 2020-07-27
!--:page title" -- Red blood cells help the body fight infection simply by transporting oxygen from the lungs to the body's organs, but also by capturing pathogens on the cell surface, neutralizing pa
-
Nature solves the mystery of acidic environments "assisting" tumor immunity.
Time of Update: 2020-07-23
in previous studies, it was found that vista can inhibit the activity of T cells and help tumor resist immunotherapy with PD-1 and ctla-1 antibodies [2,3].
these results suggest that vista can selectively inhibit T cell function, but it is still unclear whether Vista binds to its receptors through histidine rich domains.
-
NC. Pan-cancer methylation combined immune escape.
Time of Update: 2020-07-23
consistent with Pan cancer molecular data analysis, global hypomethylation samples showed high mutation load and aneuploidy and CGI hypermethylation in short PMD (Fig. 5d).
-
Sci Signaling . . . The results of the Guo Fei team reveal important molecular mechanisms that regulate cGAS-induced DNA.
Time of Update: 2020-07-23
on November 26, Guo Fei, Institute of pathogenic biology, Chinese Academy of Medical Sciences, published a paper entitled PKR dependent cytosolic CGAs foci are necessary for intracellular DNA sensing on science signaling.
-
Immunity . . . The Zhong Chao/Zhu Jinfang collaboration reveals the genealogical determining mechanism in the development of inherent lymphocytes.
Time of Update: 2020-07-23
on December 24, 2019, the team of Zhong Chao of Peking University and Zhu JinFang, a senior researcher of NIH, published the results of differential expression of the transcription factor GATA3 specifications lineage and functions of innate lymphoma cells in the development of ILC ILC plays an important role in determining its fate.
-
Plant Physiol. The Zhejiang University/Cornell University team found that low temperatures enhanceplant immunity through the antagonisticity of ethylene and salicylic acid signals.
Time of Update: 2020-07-23
recently, plant physiology published a research paper entitled "low temperature enhancement plant immunity via salicylic acid pathway genes that are expressed by ethylene" by Guan Yajing, School of agriculture and biotechnology, Zhejiang University, and Professor Hua Jian, Cornell University, USA (the first author is Li Zhan), revealing the mechanism of low temperature regulating the resistance of Arabidopsis thaliana to Pseudomonas syringae.
-
Nature sub-journal: CRISPR joins forces with viral genes! Start new immunogene therapy to capture "runaway" cancer cells.
Time of Update: 2020-07-23
so, Professor Chen Sidi and the researchers of his team wondered: can there be a new immunotherapy that can not only "activate" the expression and presentation of tumor cell surface specific antigens, but also "activate" the tumor microenvironment to help the immune system recognize "camouflaged" cancer cells?
